Omada Health Reports Second Quarter 2025 Results

Core Viewpoint - Omada Health, Inc. reported strong financial results for the second quarter of 2025, highlighting a 49% year-over-year revenue growth and significant member growth, indicating progress towards profitability [2][4]. Financial Performance - Revenue reached $61 million, representing a 49% increase compared to the second quarter of 2024 [8]. - Total members grew to 752,000, a 52% increase year-over-year [8]. - Gross margin improved to 66%, up from 60% in the same quarter of the previous year [9]. - Non-GAAP gross margin was 68%, compared to 63% in the second quarter of 2024 [9]. - The net loss narrowed to $5 million, down from a net loss of $11 million in the second quarter of 2024 [9]. - Adjusted EBITDA loss was $0.2 million, significantly improved from a loss of $6.8 million in the same quarter of 2024 [9]. Financial Outlook - For the year ending December 31, 2025, Omada expects revenue in the range of $235 million to $241 million [9]. - Adjusted EBITDA loss is projected to be between $9 million and $5 million [9]. Debt Management - On July 31, 2025, Omada fully repaid $31.0 million in principal and $0.4 million in accrued interest under its term loan facility and revolving line of credit, ahead of schedule [6]. Product and Service Development - The company has seen success with its GLP-1 companion programs, which are now available through two of the largest pharmacy benefit managers in the U.S. [8]. - In May, Omada introduced an AI-agent named OmadaSpark, aimed at providing real-time motivational interviewing and nutrition education to members [8]. Company Background - Omada Health is a virtual-first healthcare provider focused on chronic disease management, with over a decade of experience and a wide customer base exceeding 2,000 clients [11].